VC firm Movac leads $4.75m seed round for medtech startup Avasa
The startup will use the funds to get US regulatory approval for its arterial coupler.
Avasa's coupler would be a direct purchase by hospitals for use on patients undergoing surgery.
Movac has led a pre-Series A capital raise by Auckland medtech startup Avasa, which has done a first close of $4.75 million.
Founded by clinician-bioengineer Dr Nandoun Abeysekera in 2018, the company has developed an arterial coupler that simplifies microvascular surgery.
The current standard of
Want to read more? It's easy.
Choose your subscription
Already have an account? Login
Smartphone Only Subscription
NZ$29.95 / monthly
Monthly Premium Online Subscription
NZ$49.95 / monthly
Smartphone Only Annual Subscription
NZ$299.00 / yearly
Yearly Premium Online Subscription
NZ$499.00 / yearly
Premium Group Membership 10 Users
NZ$385+GST / monthly
$38.5 per user - Pay by monthly
credit card debit
Premium Group Membership 20 Users
NZ$660+GST / monthly
$33 per user - Pay by monthly
credit card debit
Premium Group Membership 50 Users
NZ$1375+GST / monthly
$27.5 per user - Pay by monthly
credit card debit
Premium Group Membership 100 Users
NZ$2100+GST / monthly
$21 per user - Pay by monthly
credit card debit
Yearly Premium Online Subscription + NBR Marketplace
NZ$999.00 / yearly
Individual
Group membership
NBR Marketplace
Student
Exclusive FREE offer for uni students studying at a New Zealand university (valued at $499).
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
